SION

NASDAQ open

Sionna Therapeutics

2.94 USD
▼-0.03-0.91%
盘后 3.25 0.00%
2026-11-20
市值
$127.79M
市盈率
—
EPS
-2.43
股息率
—
52 周区间
2.89 – 54.97
成交量
27.79K
Beta
—
目标价
21.00
52W 低 2.8952W 高 54.97
价格走势

公司简介

Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1...

关联新闻